Aktie A40519 CHINA PHARMA HOLDINGS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen China Pharma Holdings, Inc.

Aktien

A40519

US16941T3023

CPHI

Markt geschlossen - Nyse
Andere Börsenplätze
 22:00:00 07.05.2024 		% 5 Tage % 1. Jan.
0.315 USD -1.53% Intraday Chart für China Pharma Holdings, Inc. +2.57% -47.93%
01.04. China Pharma Holdings, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
23.02. China Pharma führt 1-für-5 Aktiensplit durch; Aktien fallen nachbörslich MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
China Pharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
China Pharma to Conduct 1-For-5 Reverse Stock Split; Shares Fall After-Hours
China Pharma Holdings, Inc. Announces the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device
North China Pharmaceutical Gets Nod to Market Ampicillin API
China Pharma Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
China Pharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
China Pharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CHINA PHARMA HOLDINGS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
North China Pharma Unit Passes Compliance Inspection
CHINA PHARMA HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
China Pharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
China Pharma Holdings, Inc. Auditor Raises 'Going Concern' Doubt
China Pharma : Current Report - Form 8-K
CHINA PHARMA HOLDINGS, INC. : Other Events (form 8-K)
CHINA PHARMA HOLDINGS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
CHINA PHARMA HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask
China Pharma : Dec. 28, 2022_China Pharma Holdings, Inc. Announced the Launch of N95 Medical Pr
China Pharma Holdings, Inc. Announces Launch of N95 Medical Protective Mask
China Pharma : Dec. 5, 2022_China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Di
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A40519 Aktie
  4. Nachrichten China Pharma Holdings, Inc.
  5. Andere Sprachen